Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 14, 2013
Grant Date -
Feb 11, 2010
app pub date -
Oct 4, 2007
filing date -
Oct 4, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine comprising the immunogenic glycopeptide. Another aspect is an antibody generated using the immunogenic glycopeptide and the use of said antibody in therapy and diagnosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully